DEVELOPMENT OF QUANTITATIVE PROTOCOL FOR IMATINIB IN HUMAN SERUM BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY FOR THERAPEUTIC DRUG MONITORING